MD, FACS, DABVLM
Get to know Dr. Deol
Zoe Deol MD, FACS was born in Rhode Island and raised in Ohio. Dr. Deol moved to Michigan in 1986 to attend Albion College, and has called Michigan her home ever since. After receiving her bachelor’s degree in biology from Albion College in 1990, she went on to receive her MD from Michigan State University in 1994. She completed her general surgery internship at The Cleveland Clinic in Ohio in 1995, and then completed a six-year general surgery residency at William Beaumont Hospital in Royal Oak, Michigan in 2001. Following this, Dr. Deol went on to sub-specialize in laparoscopic bariatric surgery by completing a Fellowship at Loyola University Medical Center in Chicago. From that point, she dedicated her career to designing a multi-disciplinary surgical practice for the evaluation and treatment of all aspects of obesity. During her years in private practice at William Beaumont Hospital in a suburb of Detroit, she completed two additional mini-fellowships in bariatric surgery: one in Pittsburgh with the nation’s leading bariatric surgeon, Philip Schauer, MD (who is now the chief of bariatric surgery at The Cleveland Clinic); and the other in Melbourne Australia with the internationally renowned Paul O’Brien, MD, FRACS, MBBS who is a past council member of the International Federation for the Surgery of Obesity.
Dr. Deol's Credentials
- General Surgery
- American Board of Venous and Lymphatic Medicine
- Michigan State University (Lansing, MI)
- Internship at the Cleveland Clinic (Cleveland, OH)
- Residency at William Beaumont Hospital (Royal Oak, Michigan)
- American Vein and Lymphatic Soceity (AVLS)
- American Venous Forum (AVF)
- Spider Veins
- Varicose Veins
- Vascular Surgery
- Venous Insufficiency
More About Dr. Deol
Once her bariatric surgery patients lost weight, they sought to treat the varicose veins, heaviness, and fatigue in their legs, which hindered their ability to exercise and maintain their weight loss. Her prior residency training in vascular surgery provided the foundation for her transition into minimally invasive endovenous surgery. After leaving her private practice in to accept a position in Chicago, she later returned to Detroit, and devoted her entire career to the treatment of venous disease. Her return to Michigan coincided with the 2008 rescission, and Detroit was among the hardest-hit cities in the country. The plight of the autoworkers struck a cord with her, and she focused her efforts on providing them with the much-needed care for the many hours they worked standing on the line in the factories.
“Detroit was the backbone by which this country was supported for decades, and I saw her through one of the biggest blows since the depression. She is a city of hope and tenacity, and this is due entirely to its people. The autoworkers are the legs upon which this city stands. It is my personal passion to provide them, and all of the equally hard working residents of Detroit and the surrounding cities, the care they so rightfully deserve.”
Dr. Deol has become an integral part of the academic venous world, and was invited by the President of the American Vein and Lymphatic Society (AVLS) to serve as a representative of the United States on their International Committee. This position affords her the opportunity to fill a diplomatic role while staying abreast of the latest vein techniques being used around the world. Additionally, Dr. Deol accepted an invitation from another prestigious national organization, the American Venous Forum (AVF), to serve on their Website and Social Media Committee. Her role on that committee is to improve the organization’s capacity to educate the general public about venous disease. She is also a member of the American Medical Society (AMA), American College of Surgeons (ACS), the American Society of Bariatric and Metabolic Surgery (ASMBS), the American Professional Wound Care Association (APWCA), and the Michigan State Medical Society (MSMS).
Most recently, Dr. Deol conducted a case study on Varithena and how the treatment can resolve activity limiting symptoms after profound weight loss.